Integra Biosciences Miro Canvas

Integra Biosciences has launched the Miro Canvas digital microfluidics platform for fully automated next-generation sequencing sample preparation. The system uses gentle sample handling to maintain the integrity of high molecular weight DNA and minimizes reagent usage for long-read sequencing library preparation. Miro Canvas can also automate exome and other hybrid capture protocols, and requires only 15 minutes of hands on time per run, the company said. The platform was originally developed by Miroculus, which Integra acquired earlier this year.